Skip to main content
Fig. 1 | Infectious Agents and Cancer

Fig. 1

From: HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile

Fig. 1

HPV16/18 genotyping results and outcomes of the hrHPV positive participants of a population-based screening trial in Chile, 2010. *Missing = 53 women with insufficient sample material for reflex testing plus 53 women who did not comply with colposcopy. hrHPV: high-risk human papillomavirus; CIN2+: cervical intraepithelial neoplasia grade 2 or worse; CIN3+: cervical intraepithelial neoplasia grade 3 or worse

Back to article page